5 Stanley Druckenmiller Recursion Pharmaceuticals Trades
Stanley Druckenmiller started to build up the position in Recursion Pharmaceuticals in Q3 2021 and continued to invest until Q3 2022. Since then they sold 1.39 Million shares. The investor completely sold their stake between Q3 2023 and Q1 2024.
Avg closing price
Price range
Sold -907 Thousand shares
Q1 2024
Avg closing price
$11.14
Price range
$9.13
-
$15.52
Sold 34.6% shares (-479 Thousand shares)
Q3 2023
Avg closing price
$9.98
Price range
$6.59
-
$15.86
Increased shares by 406.5% (+1.11 Million shares)
Q3 2022
Avg closing price
$10.13
Price range
$7.83
-
$13.60
Increased shares by 5.3% (+13.7 Thousand shares)
Q1 2022